SG

Sector Gamma As

Sector-focusedMomentum followerDiversified strategy

Total reported value

$423.5M

Reporting period: 2026-03-31 · Number of holdings: 42

SECTOR GAMMA AS disclosed 42 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $423.5M and a quarterly turnover rate of 42.2%.

Personality snowflake

Concentration
17.75
Portfolio Stability
42.21
Momentum/Contrarian
100
Sector conviction
100
Diversification
84
Sizing Uniformity
90.59

Recent moves

  • Trim GILD

    -69.8%　-$14.2M

  • Trim BDX

    -37.6%　-$12.7M

  • Add BMY

    +11.0%　$10.0M

  • Add PFE

    +27.0%　$9.2M

  • Trim MRK

    -28.4%　-$7.0M

  • Trim CNC

    -37.1%　-$5.3M

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1BMYBristol-myers Squibb CoStock-Healthcare11.86%+2.69%+10.99%
2MRKMerck & Co. INC.Stock-Healthcare7.39%-1.33%-28.41%
3PFEPfizer INCStock-Healthcare7.24%+2.36%+26.97%
4MDTMedtronic plcStock-Healthcare5.74%-0.16%+4.09%
5INCYIncyte CORPStock-Healthcare4.46%-0.47%-8.35%
6AMGNAmgen INCStock-Healthcare3.92%-0.63%-22.64%
7BIIBBiogen INCStock-Healthcare3.90%+0.47%+5.41%
8ZBHZimmer Biomet Holdings INCStock-Healthcare3.33%+0.61%+17.63%
9BMRNBiomarin Pharmaceutical INCStock-Healthcare3.20%+0.51%+20.86%
10BDXBecton Dickinson And CoStock-Healthcare3.07%-2.79%-37.59%
11ELVElevance Health INCStock-Healthcare3.04%+0.44%+35.08%
12IONSIonis Pharmaceuticals INCStock-Healthcare3.00%-0.34%-8.38%
13CAHCardinal Health INCStock-Healthcare2.74%-0.16%-11.38%
14UNHUnitedhealth Group INCStock-Healthcare2.33%+2.33%NEW
15CVSCvs Health CORPStock-Healthcare2.30%-0.91%-23.80%
16BRKRBruker CORPStock-Healthcare2.17%-0.57%-0.27%
17GEHCGE Healthcare TechnologyStock-Healthcare2.12%-0.02%+10.51%
18ABTAbbott LaboratoriesStock-Healthcare2.12%+2.12%NEW
19GILDGilead Sciences INCStock-Healthcare1.75%-3.19%-69.82%
20LNTHLantheus Holdings INCStock-Healthcare1.67%+0.25%-0.51%
21IQVIqvia Holdings INCStock-Healthcare1.62%+1.62%NEW
22SNDXSyndax Pharmaceuticals INCStock-Other1.58%+0.37%+13.47%
23BIOBio-rad Laboratories-aStock-Healthcare1.56%-0.08%—
24QGENQiagen N.V.Stock-Healthcare1.54%+1.54%NEW
25AVTRAvantor INCStock-Healthcare1.29%-0.53%—
26CNCCentene CORPStock-Healthcare1.26%-1.16%-37.08%
27TNDMTandem Diabetes Care INCStock-Other1.21%-0.13%—
28PTCTPtc Therapeutics INCStock-Healthcare1.21%+0.14%+21.12%
29LHLabcorp Holdings INCStock-Healthcare1.20%-0.35%-29.61%
30ASNDAscendis Pharma A/SStock-Other1.15%+0.36%+30.67%
31EWEdwards Lifesciences CORPStock-Healthcare1.14%-0.73%-37.34%
32DXCMDexcom INCStock-Healthcare0.83%-0.32%-26.27%
33CRNXCrinetics Pharmaceuticals InStock-Other0.81%-0.41%-18.09%
34KURAKura Oncology INCStock-Other0.79%-0.29%-9.66%
35HUMHumana INCStock-Healthcare0.79%+0.79%NEW
36BBIOBridgebio Pharma INCStock-Healthcare0.78%+0.78%NEW
37IOVAIovance Biotherapeutics INCStock-Other0.75%+0.75%NEW
38DNLIDenali Therapeutics INCStock-Other0.74%+0.74%NEW
39ARDXArdelyx INCStock-Other0.73%+0.73%NEW
40COGTCogent Biosciences INCStock-Other0.73%+0.73%NEW
41OGNOrganon & CoStock-Healthcare0.53%+0.04%+25.32%
42ARWRArrowhead Pharmaceuticals InStock-Healthcare0.44%+0.44%NEW

Holding changes this quarter

Sector Gamma As's most significant position changes for 2026-03-31: Sold out: Thermo Fisher Scientific INC (TMO); New buy: Unitedhealth Group INC (UNH); New buy: Abbott Laboratories (ABT); New buy: Iqvia Holdings INC (IQV); New buy: Qiagen N.V. (QGEN).

Position changes disclosed by Sector Gamma As for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction
1BMYBristol-myers Squibb Co+2.7%+10.99%Add
2PFEPfizer INC+2.4%+26.97%Add
3ZBHZimmer Biomet Holdings INC+0.6%+17.63%Add
4BMRNBiomarin Pharmaceutical INC+0.5%+20.86%Add
5BIIBBiogen INC+0.5%+5.41%Add
6ELVElevance Health INC+0.4%+35.08%Add
7SNDXSyndax Pharmaceuticals INC+0.4%+13.47%Add
8ASNDAscendis Pharma A/S+0.4%+30.67%Add
9LNTHLantheus Holdings INC+0.3%-0.51%Trim
10PTCTPtc Therapeutics INC+0.1%+21.12%Add
11OGNOrganon & Co0%+25.32%Add
12GEHCGE Healthcare Technology0%+10.51%Add
13BIOBio-rad Laboratories-a-0.1%—Unchanged
14TNDMTandem Diabetes Care INC-0.1%—Unchanged
15MDTMedtronic plc-0.2%+4.09%Add
16CAHCardinal Health INC-0.2%-11.38%Trim
17KURAKura Oncology INC-0.3%-9.66%Trim
18DXCMDexcom INC-0.3%-26.27%Trim
19IONSIonis Pharmaceuticals INC-0.3%-8.38%Trim
20LHLabcorp Holdings INC-0.4%-29.61%Trim
21CRNXCrinetics Pharmaceuticals In-0.4%-18.09%Trim
22INCYIncyte CORP-0.5%-8.35%Trim
23AVTRAvantor INC-0.5%—Unchanged
24BRKRBruker CORP-0.6%-0.27%Trim
25AMGNAmgen INC-0.6%-22.64%Trim
26EWEdwards Lifesciences CORP-0.7%-37.34%Trim
27CVSCvs Health CORP-0.9%-23.80%Trim
28CNCCentene CORP-1.2%-37.08%Trim
29MRKMerck & Co. INC.-1.3%-28.41%Trim
30BDXBecton Dickinson And Co-2.8%-37.59%Trim
31GILDGilead Sciences INC-3.2%-69.82%Trim
32TMOThermo Fisher Scientific INC—EXITSold out
33UNHUnitedhealth Group INC—NEWNew buy
34ABTAbbott Laboratories—NEWNew buy
35IQVIqvia Holdings INC—NEWNew buy
36QGENQiagen N.V.—NEWNew buy
37REGNRegeneron Pharmaceuticals—EXITSold out
38HCAHca Healthcare INC—EXITSold out
39HUMHumana INC—NEWNew buy
40BBIOBridgebio Pharma INC—NEWNew buy
41IOVAIovance Biotherapeutics INC—NEWNew buy
42DNLIDenali Therapeutics INC—NEWNew buy
43ARDXArdelyx INC—NEWNew buy
44COGTCogent Biosciences INC—NEWNew buy
45CGONCg Oncology INC—EXITSold out
46CERTCertara INC—EXITSold out
47ARWRArrowhead Pharmaceuticals In—NEWNew buy

FAQ

What is Sector Gamma As and what type of investor is it?
Sector Gamma As is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $423.5M, spread across 42 disclosed positions.
What are Sector Gamma As's largest equity positions?
Based on the latest 13F filing, Sector Gamma As's top holdings by market value are: 1. Bristol-myers Squibb Co (BMY) — $50.2M (11.9%) 2. Merck & Co. INC. (MRK) — $31.3M (7.4%) 3. Pfizer INC (PFE) — $30.6M (7.2%) 4. Medtronic plc (MDT) — $24.3M (5.7%) 5. Incyte CORP (INCY) — $18.9M (4.5%)
What changes did Sector Gamma As make in its most recent portfolio filing?
In the latest reported quarter, Sector Gamma As made 44 notable position adjustments: 11 new positions were initiated, 12 existing holdings were added to, 16 positions were partially reduced, and 5 were completely exited. The largest of these moves: Sold out: Thermo Fisher Scientific INC (TMO); New buy: Unitedhealth Group INC (UNH); New buy: Abbott Laboratories (ABT); New buy: Iqvia Holdings INC (IQV); New buy: Qiagen N.V. (QGEN)
What sectors does Sector Gamma As focus on?
Sector Gamma As is concentrated in the following sectors based on its current disclosed equity portfolio: • Health Care: 100.0%